Journal of Clinical Endocrinology & Metabolism, Vol 81, 4458-4461, Copyright © 1996 by Endocrine Society

ARTICLES

Identification of novel missense mutations (Phe310Leu and Gly439Arg) in a neonatal case of hypophosphatasia

K Ozono, M Yamagata, T Michigami, S Nakajima, N Sakai, G Cai, K Satomura, N Yasui, S Okada and M Nakayama
Department of Environmental Medicine, Osaka Medical Center, Japan.

Hypophosphatasia is associated with a defect of the tissue-non-specific alkaline phosphatase gene. We performed a mutational analysis in a surviving patient diagnosed at birth as having hypophosphatasia, on the basis of a low level of serum alkaline phosphatase (ALP) activity and characteristic radiographical findings. She had two sisters, one of whom died of respiratory failure complicated by perinatal hypophosphatasia; the other seemed healthy, with a relatively low activity level of ALP. The patient's parents also had low ALP activity. Sequence analysis of the tissue-nonspecific alkaline phosphatase gene was performed, using genomic DNA and total RNA from the skin fibroblasts of the patient and the peripheral mononuclear cells of her parents. The conversion of Phe to Leu at codon 310 (F310L) and Gly to Arg at 439 (G439R) were identified in the patient. Interestingly, the reconstructive experiments demonstrated that the F310L mutant exhibited an ALP activity level 65% of the normal level, whereas the mutant G439R had no activity. Moreover, the digestion by StuI, after a PCR using complementary DNA extracted from fibroblasts of the patient and lymphocytes of her father, revealed a relatively low messenger RNA level of F310L. These findings suggest that the neonatal case of hypophosphatasia was associated with compound mutations, one of which caused the loss of ALP activity and the other of which caused a slight reduction of the ALP activity, with a relatively low level of messenger RNA.

This article has been cited by other articles:

				D. A. Stevenson, J. C. Carey, S. P. Coburn, K. L. Ericson, J. L. B. Byrne, S. Mumm, and M. P. Whyte Autosomal Recessive Hypophosphatasia Manifesting in Utero with Long Bone Deformity but Showing Spontaneous Postnatal Improvement J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3443 - 3448. [Abstract] [Full Text] [PDF]

				A. Taillandier, S.-L. Sallinen, I. Brun-Heath, P. De Mazancourt, J.-L. Serre, and E. Mornet Childhood Hypophosphatasia Due to a de Novo Missense Mutation in the Tissue-Nonspecific Alkaline Phosphatase Gene J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2436 - 2439. [Abstract] [Full Text] [PDF]

				M Herasse, M Spentchian, A Taillandier, K Keppler-Noreuil, A N M Fliorito, J Bergoffen, R Wallerstein, C Muti, B Simon-Bouy, and E Mornet Molecular study of three cases of odontohypophosphatasia resulting from heterozygosity for mutations in the tissue non-specific alkaline phosphatase gene J. Med. Genet., August 1, 2003; 40(8): 605 - 609. [Full Text] [PDF]

				H. L. Müller, M. Yamazaki, T. Michigami, T. Kageyama, E. Schönau, P. Schneider, and K. Ozono Asp361Val Mutant of Alkaline Phosphatase Found in Patients with Dominantly Inherited Hypophosphatasia Inhibits the Activity of the Wild-Type Enzyme J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 743 - 747. [Abstract] [Full Text]

				T.C. Hart, M.L. Marazita, and J.T. Wright The Impact of Molecular Genetics on Oral Health Paradigms Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(1): 26 - 56. [Abstract] [Full Text] [PDF]

				G. Cai, T. Michigami, T. Yamamoto, N. Yasui, K. Satomura, M. Yamagata, M. Shima, S. Nakajima, S. Mushiake, S. Okada, et al. Analysis of Localization of Mutated Tissue-Nonspecific Alkaline Phosphatase Proteins Associated with Neonatal Hypophosphatasia Using Green Fluorescent Protein Chimeras J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3936 - 3942. [Abstract] [Full Text]